BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10213642)

  • 1. Persistent lupus activity in end-stage renal disease.
    Krane NK; Burjak K; Archie M; O'donovan R
    Am J Kidney Dis; 1999 May; 33(5):872-9. PubMed ID: 10213642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease.
    Salgado Guerrero M; Londono Jimenez A; Dobrowolski C; Mowrey WB; Goilav B; Wang S; Broder A
    BMC Nephrol; 2020 Oct; 21(1):450. PubMed ID: 33115441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of lupus activity in end-stage renal disease treated by hemodialysis.
    Okano K; Yumura W; Nitta K; Uchida K; Ohnuki T; Kawashima A; Nihei H
    Intern Med; 2001 Jul; 40(7):598-602. PubMed ID: 11506299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities.
    Pahl MV; Vaziri ND; Saiki JK; Upham T; Ness R
    Artif Organs; 1984 Nov; 8(4):423-8. PubMed ID: 6334509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis.
    Goo YS; Park HC; Choi HY; Kim BS; Park YB; Lee SK; Kang SW; Kim SI; Kim YS; Park KI; Lee HY; Han DS; Choi KH
    Yonsei Med J; 2004 Apr; 45(2):199-206. PubMed ID: 15118989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature.
    Mattos P; Santiago MB
    Clin Rheumatol; 2012 Jun; 31(6):897-905. PubMed ID: 22415467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease in lupus: disease activity, dialysis, and the outcome of transplantation.
    Stone JH
    Lupus; 1998; 7(9):654-9. PubMed ID: 9884106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus in patients with chronic renal failure.
    Cheigh JS; Stenzel KH; Rubin AL; Chami J; Sullivan JF
    Am J Med; 1983 Oct; 75(4):602-6. PubMed ID: 6353915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE.
    Nossent HC; Swaak TJ; Berden JH
    Am J Med; 1990 Aug; 89(2):169-74. PubMed ID: 2382665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort.
    Ribeiro FM; Leite MA; Velarde GC; Fabris CL; Santos RC; Lugon JR
    Am J Nephrol; 2005; 25(6):596-603. PubMed ID: 16282677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.
    Plantinga LC; Lim SS; Patzer RE; Pastan SO; Drenkard C
    BMC Nephrol; 2016 Jul; 17(1):64. PubMed ID: 27388761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.
    Swai J; Zhao X; Noube JR; Ming G
    BMC Nephrol; 2020 May; 21(1):156. PubMed ID: 32357924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis.
    Rodby RA; Korbet SM; Lewis EJ
    Am J Med; 1987 Oct; 83(4):613-8. PubMed ID: 3499820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients.
    Lee PT; Fang HC; Chen CL; Chiou YH; Chou KJ; Chung HM
    Lupus; 2003; 12(11):827-32. PubMed ID: 14667098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis.
    Liang CC; Huang CC; Wang IK; Chang CT; Chen KH; Weng CH; Lin JL; Hung CC; Yang CW; Yen TH
    Ther Apher Dial; 2010 Feb; 14(1):35-42. PubMed ID: 20438518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplantation in lupus nephritis: a Brazilian cohort.
    Oliveira CS; d Oliveira I; Bacchiega AB; Klumb EM; Albuquerque EM; Souza E; Suassuna JH; Ribeiro FM
    Lupus; 2012 Apr; 21(5):570-4. PubMed ID: 22129601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity.
    Cheigh JS; Kim H; Stenzel KH; Tapia L; Sullivan JF; Stubenbord W; Riggio RR; Rubin AL
    Am J Kidney Dis; 1990 Sep; 16(3):189-95. PubMed ID: 2399912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes.
    Weng CH; Hsu CW; Yu CC; Yen TH; Yang CW; Hung CC
    Kidney Blood Press Res; 2009; 32(6):451-6. PubMed ID: 20016213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with active systemic lupus erythematosus after endstage renal disease.
    Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
    J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.